BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32358736)

  • 1. Survival outcomes following craniotomy for intracranial metastases from an unknown primary.
    Gough M; Nielsen M; Coulter IC; Holliman D
    Int J Clin Oncol; 2020 Aug; 25(8):1475-1482. PubMed ID: 32358736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
    Shaw PH; Adams R; Jordan C; Crosby TD
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.
    Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR
    PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
    Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
    BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical resection of brain metastases from renal cell carcinoma in 50 patients.
    Wroński M; Arbit E; Russo P; Galicich JH
    Urology; 1996 Feb; 47(2):187-93. PubMed ID: 8607231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remaining Lifespan of Patients Aged ≥65 Years Receiving Whole-brain Irradiation for Metastases from Cancer of Unknown Primary.
    Rades D; Nguyen T; Khoa MT; Janssen S; Schild SE
    Anticancer Res; 2020 Apr; 40(4):2261-2264. PubMed ID: 32234923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Factors for Local Control and Survival in Patients with Cancer of Unknown Primary (CUP) Irradiated for Cerebral Metastases.
    Rades D; Dziggel L; Janssen S; Khoa MT; Duong VN; Khiem VH; Gebauer N; Bartscht T; Schild SE
    Anticancer Res; 2018 Apr; 38(4):2415-2418. PubMed ID: 29599370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment for brain metastases: prognostic factors and survival in 177 patients.
    Stark AM; Tscheslog H; Buhl R; Held-Feindt J; Mehdorn HM
    Neurosurg Rev; 2005 Apr; 28(2):115-9. PubMed ID: 15609059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma Knife Radiosurgery for Metastatic Brain Tumors from Cancer of Unknown Primary.
    Matsunaga S; Shuto T; Kobayashi N
    World Neurosurg; 2019 Feb; 122():e1465-e1471. PubMed ID: 30468925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metastases in patients with cancer of unknown primary.
    Bartelt S; Lutterbach J
    J Neurooncol; 2003 Sep; 64(3):249-53. PubMed ID: 14558600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resection of brain metastases from colorectal carcinoma in 73 patients.
    Wroński M; Arbit E
    Cancer; 1999 Apr; 85(8):1677-85. PubMed ID: 10223560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome after craniotomy for recurrent cranial metastases.
    Kennion O; Holliman D
    Br J Neurosurg; 2017 Jun; 31(3):369-373. PubMed ID: 28290227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
    Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
    Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-do Craniotomy for Recurrent Grade IV Glioblastomas: Impact and Outcomes from the National Neuroscience Institute Singapore.
    Chen MW; Morsy AA; Liang S; Ng WH
    World Neurosurg; 2016 Mar; 87():439-45. PubMed ID: 26585720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metastases in breast cancer: prognostic factors and management.
    Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
    Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective study of 127 surgically treated patients with multiple brain metastases: indication, prognostic factors, and outcome.
    Schackert G; Lindner C; Petschke S; Leimert M; Kirsch M
    Acta Neurochir (Wien); 2013 Mar; 155(3):379-87. PubMed ID: 23314988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment for brain metastases: Prognostic factors and survival in 309 patients with regard to patient age.
    Stark AM; Stöhring C; Hedderich J; Held-Feindt J; Mehdorn HM
    J Clin Neurosci; 2011 Jan; 18(1):34-8. PubMed ID: 20851611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients.
    Hong YW; Lin JD; Yu MC; Hsu CC; Lin YS
    Int J Surg; 2018 Jul; 55():182-187. PubMed ID: 29883619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.